Tiziana Life Sciences Ltd (TLSA)

Currency in USD
1.010
-0.030(-2.88%)
Closed·
1.020+0.010(+0.99%)
·
TLSA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.0001.080
52 wk Range
0.7612.330
Key Statistics
Prev. Close
1.01
Open
1.03
Day's Range
1-1.08
52 wk Range
0.761-2.33
Volume
382.73K
Average Volume (3m)
662.89K
1-Year Change
-50.9709%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TLSA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
7.898
Upside
+681.93%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Tiziana Life Sciences Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.898
(+681.93% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BTIG
Buy7.00+593.07%-New CoverageSep 03, 2026

Earnings

Latest Release
May 01, 2026
EPS / Forecast
-0.11 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

TLSA Income Statement

Compare TLSA to Peers and Sector

Metrics to compare
TLSA
Peers
Sector
Relationship
P/E Ratio
−7.1x−1.6x−0.4x
PEG Ratio
0.18−0.040.00
Price/Book
2,511.5x3.7x2.6x
Price / LTM Sales
-4.2x3.1x
Upside (Analyst Target)
-130.4%57.4%
Fair Value Upside
Unlock7.4%7.7%Unlock

Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally. It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer’s disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases. The company is headquartered in London, the United Kingdom.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
200.70K0.16%202.71K
Other Institutional Investors
2.31M1.78%2.33M
Public Companies & Retail Investors
126.80M98.06%128.07M
Total
129.31M100.00%130.6M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dauntless Investment Group, Llc0.90%1,162,0001,174
Mid-American Wealth Advisory Group Inc.0.25%323,240326

People Also Watch

2.60
RCKT
-3.35%
19.11
LEGN
+0.26%
1.205
ALDX
-1.23%
0.797
PDSB
-0.37%
0.3516
COSM
-7.50%

FAQ

What Is the Tiziana Life Sciences (TLSA) Stock Price Today?

The Tiziana Life Sciences stock price today is 1.010 USD.

What Stock Exchange Does Tiziana Life Sciences Trade On?

Tiziana Life Sciences is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Tiziana Life Sciences?

The stock symbol for Tiziana Life Sciences is "TLSA."

What Is the Tiziana Life Sciences Market Cap?

As of today, Tiziana Life Sciences market cap is 130.600M USD.

What Is Tiziana Life Sciences's Earnings Per Share (TTM)?

The Tiziana Life Sciences EPS (TTM) is -0.156.

From a Technical Analysis Perspective, Is TLSA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Tiziana Life Sciences Stock Split?

Tiziana Life Sciences has split 0 times.

How Many Employees Does Tiziana Life Sciences Have?

Tiziana Life Sciences has 10 employees.

What is the current trading status of Tiziana Life Sciences (TLSA)?

As of Sep 28, 2026, Tiziana Life Sciences (TLSA) is trading at a price of 1.010 USD, with a previous close of 1.010 USD. The stock has fluctuated within a day range of 1.000 USD to 1.080 USD, while its 52-week range spans from 0.761 USD to 2.330 USD.

What Is Tiziana Life Sciences (TLSA) Price Target According to Analysts?

The average 12-month price target for Tiziana Life Sciences is 7.898 USD, with a high estimate of 8.86402754 USD and a low estimate of 6.93102079 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +681.93% Upside potential.

What Is the TLSA After Hours Price?

TLSA's last after hours stock price is 1.020 USD, the stock has decreased by 0.010, or 0.990%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.